B can offer those no-cost services, Massoumi aims to keep the company's budget trim - for example by avoiding expensive advertisements. Those who can't pay fill out an online form that instantly calculates whether they qualify for financial hardship based on federal poverty guidelines.'That’s when we decided to go into medications.' 'As vaccines became more widely available we started asking, 'How will we help improve health care access more broadly?'' says Massoumi.The company distributed 1.1 million vaccine doses in 90 days - and Massoumi began looking for the company's next act.B as an online matchmaking service in New York for unused vaccines, with 2.5 million people signing up. 'I always told myself with my next health care company I’d solve both parts of that equation - accessibility and equity.'Ĭontext: After his stint at Zocdoc, Massoumi started Dr. 'My greatest regret at Zocdoc is we never did enough to help the people who couldn’t afford coverage,' says Massoumi.Why it matters: As COVID surges continue and public health agencies relax safety guidelines, demand for antiviral medications such as Paxlovid is on the rise - but data suggests the drugs aren't getting to those who need them most.ĭeal details: Lerer Hippeau and Founders Fund led the fundraise.īetween the lines: Massoumi, who also founded doctor-patient matching startup Zocdoc, plans to offer the antivirals for free to those who can't afford them. B raised $8 million as it pivots to virtual COVID treatment distribution, CEO Cyrus Massoumi tells Axios exclusively.

Zocdoc vaccine